ORNBV Orion Oyj

80.85EUR+0.06%Mkt Cap: 12.34B $P/E: 19.39

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…

Key Statistics

Company
Market Cap12.34B USD
Enterprise Value12.37B USD
Revenue (TTM)2.24B USD
Gross Profit1.32B USD
Net Income (TTM)543.80M USD
Revenue/Share14.62 EUR
Last Price80.85 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.0K
CountryFI
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFI0009014377
Valuation
P/E (Trailing)19.39
P/E (Forward)17.02
PEG5.73
EV/EBITDA14.34
EV/Revenue5.53
P/S5.51
P/B8.97
EPS (TTM)4.18
EPS (Forward)4.75
52W Range
56.5087% of range84.60
52W High84.60 EUR
52W Low56.50 EUR
Profitability
Gross Margin64.20%
Oper. Margin33.84%
EBITDA Margin38.58%
Profit Margin26.48%
ROE38.95%
ROA24.89%
Growth
Revenue Growth25.20%
Earnings Growth69.50%
Cash Flow & Leverage
Operating CF344.35M USD
CapEx (TTM)106.09M USD
FCF Margin13.06%
FCF Yield2.37%
Net Debt2.72M USD
Net Debt/EBITDA0.00
Balance Sheet
Debt/Equity0.24
Current Ratio2.64
Quick Ratio1.48
Book Value/Sh9.01 EUR
Cash/Share0.92 EUR
Dividends
Fwd Div Rate1.80 EUR
Trail. Div Rate1.80 EUR
Div. Yield2.23%
5Y Avg Yield2.96%
Payout Ratio41.25%
Ex-Div DateOct 19, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)76.67 EUR
Upside (mean)-5.2%
Target Range55.00 EUR – 86.00 EUR
55.00-5.2% to mean86.00
# Analysts6
Ownership
Shares Out.108.99M
Float123.49M
Insiders2.63%
Institutions45.64%
Technical
SMA 5080.40 (+0.6%)
SMA 20072.20 (+12.0%)
Beta0.30
S&P 52W Chg14.58%
Avg Vol (30d)146.29K
Avg Vol (10d)136.11K
Technical Indicators
RSI (14)49.2
MACD0.6622
MACD Signal0.9342
MACD Hist.-0.2720
BB Upper84.78 EUR
BB Middle81.34 EUR
BB Lower77.89 EUR
BB Width8.48%
ATR (14)1.607 EUR
Vol Ratio (20d)0.73x